Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
New York, New York–(Newsfile Corp. – January 18, 2025) – WHY: Rosen Law Firm, a global investment law firm, reminds clients of Applied Therapeutics, Inc.’s securities. (NASDAQ: NASDAQ: ) between January 3, 2024 and December 2, 2024, both dates inclusive (the “Class Period”), the relevant February 18, 2025 is the time to lead the plaintiff.
NOW: If you purchased securities of Applied Therapeutics during the Class Period you may be entitled to receive relief without paying out-of-pocket fees or expenses through the contingency fee arrangement.
WHAT YOU NEED TO DO: To join the Applied Therapeutics class action, go to https://rosenlegal.com/submit-form/?case_id=32500 or call Phillip Kim, Esq. toll free at 866-767-3653 or email case@rosenlegal.com for information about a class action. A class action lawsuit has been filed. If you wish to act as the lead plaintiff, you must remove the Court before March 18, 2025. The lead plaintiff is the party representing the other members of the class to conduct the case.
WHY ROSEN LAW: We encourage investors to select qualified advisors with a track record of success in leadership roles. Oftentimes, the companies that issue the notices don’t have the experience, the resources, or any meaningful peer recognition. Most of these firms do not litigate securities class actions, but are simply brokers who refer clients or partner with law firms that litigate the cases. Be smart when choosing advice. The Rosen Law Firm represents investors worldwide, focusing its practice on securities class action and shareholder litigation. The Rosen Law Firm achieved the largest defense settlement against a Chinese Company at that time. Rosen Law Firm is ranked No. 1 by ISS Securities Group Action (WA:) Services in the number of securities class settlements in 2017. The firm has been ranked 4th every year since 2013 and has secured hundreds of millions of dollars for investors. In 2019 alone, the firm secured over $438 million for investors. In 2020, founding partner Laurence Rosen was named by law360 as a Titan of Plaintiffs’ Bar. Most of the firm’s lawyers are recognized by Lawdragon and Super Lawyers.
FACTS OF THE CASE: According to the lawsuit, the statements made during the class were false and/or misleading because they concealed and misrepresented Applied Therapeutics’ existing protocols and procedures. Therefore, the defendants gave the investors a false impression that the protocol and best medical practices were being properly followed. The lawsuit alleges that, in fact, Applied Therapeutics did not follow the rules of testing and good clinical practice that created a very high risk that the trial data would be rejected by the US Food and Drug Administration (” FDA”). Meaning of New Drug Use. When the real facts entered the market, the lawsuit alleges that investors were harmed.
To join the Applied Therapeutics group process, go to https://rosenlegal.com/submit-form/?case_id=32500 call Phillip Kim, Esq. toll free at 866-767-3653 or email case@rosenlegal.com for information about a class action.
No Group Guaranteed. Until the group is confirmed, you are not represented by a counselor unless you have reserved one. You can choose a consultant of your choice. You may remain a member of the missing group and do nothing at this point. The investor’s ability to contribute to future recovery does not depend on serving as the lead plaintiff.
Follow us for updates on LinkedIn: https://www.linkedin.com/company/the-rosen-law-firm or on Twitter: https://twitter.com/rosen_firm or on Facebook (NASDAQ:): /www .facebook.com/rosenlawfirm.
Advertising Attorney. Preliminary results do not guarantee a similar outcome.
——————————
Contact information:
To view the source version of this release, please visit https://www.newsfilecorp.com/release/237743
